NEW YORK, May 8 (Reuters) - The chief executive of drugmaker Bristol-Myers Squibb Co bought 100,000 company shares in his first open-market purchase since taking the top post nearly two years ago, according to a regulatory filing on Thursday.
NEW YORK, May 8 (Reuters) - The chief executive of drugmaker Bristol-Myers Squibb Co bought 100,000 company shares in his first open-market purchase since taking the top post nearly two years ago, according to a regulatory filing on Thursday.
